520 related articles for article (PubMed ID: 32024607)
1. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche.
Wang Y; Sun X; Yuan S; Hou S; Guo T; Chu Y; Pang T; Luo HR; Yuan W; Wang X
Cytotherapy; 2020 Mar; 22(3):127-134. PubMed ID: 32024607
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
4. Differential niche and Wnt requirements during acute myeloid leukemia progression.
Lane SW; Wang YJ; Lo Celso C; Ragu C; Bullinger L; Sykes SM; Ferraro F; Shterental S; Lin CP; Gilliland DG; Scadden DT; Armstrong SA; Williams DA
Blood; 2011 Sep; 118(10):2849-56. PubMed ID: 21765021
[TBL] [Abstract][Full Text] [Related]
5. Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells.
Glait-Santar C; Desmond R; Feng X; Bat T; Chen J; Heuston E; Mizukawa B; Mulloy JC; Bodine DM; Larochelle A; Dunbar CE
Stem Cells; 2015 Dec; 33(12):3635-42. PubMed ID: 26388434
[TBL] [Abstract][Full Text] [Related]
6. Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model.
Sontakke P; Carretta M; Jaques J; Brouwers-Vos AZ; Lubbers-Aalders L; Yuan H; de Bruijn JD; Martens AC; Vellenga E; Groen RW; Schuringa JJ
Leukemia; 2016 Oct; 30(10):2064-2073. PubMed ID: 27125308
[TBL] [Abstract][Full Text] [Related]
7. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
Somervaille TC; Cleary ML
Cancer Cell; 2006 Oct; 10(4):257-68. PubMed ID: 17045204
[TBL] [Abstract][Full Text] [Related]
9. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche.
Hanoun M; Zhang D; Mizoguchi T; Pinho S; Pierce H; Kunisaki Y; Lacombe J; Armstrong SA; Dührsen U; Frenette PS
Cell Stem Cell; 2014 Sep; 15(3):365-375. PubMed ID: 25017722
[TBL] [Abstract][Full Text] [Related]
10. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein.
Jenkins CE; Shevchuk OO; Giambra V; Lam SH; Carboni JM; Gottardis MM; Holzenberger M; Pollak M; Humphries RK; Weng AP
Exp Hematol; 2012 Sep; 40(9):715-723.e6. PubMed ID: 22613471
[TBL] [Abstract][Full Text] [Related]
11. Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy.
Forte D; García-Fernández M; Sánchez-Aguilera A; Stavropoulou V; Fielding C; Martín-Pérez D; López JA; Costa ASH; Tronci L; Nikitopoulou E; Barber M; Gallipoli P; Marando L; Fernández de Castillejo CL; Tzankov A; Dietmann S; Cavo M; Catani L; Curti A; Vázquez J; Frezza C; Huntly BJ; Schwaller J; Méndez-Ferrer S
Cell Metab; 2020 Nov; 32(5):829-843.e9. PubMed ID: 32966766
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.
Chandran P; Le Y; Li Y; Sabloff M; Mehic J; Rosu-Myles M; Allan DS
Leuk Res; 2015 Apr; 39(4):486-93. PubMed ID: 25703353
[TBL] [Abstract][Full Text] [Related]
13. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
[TBL] [Abstract][Full Text] [Related]
14. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-CXCL6 axis affects arteriolar niche remodeling in acute myeloid leukemia.
Li L; Man J; Zhao L
Exp Biol Med (Maywood); 2021 Jan; 246(1):84-96. PubMed ID: 33167688
[TBL] [Abstract][Full Text] [Related]
16. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.
Liu Q; Chen L; Atkinson JM; Claxton DF; Wang HG
Cell Death Dis; 2016 Sep; 7(9):e2361. PubMed ID: 27607576
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of AML Mouse Model by Transplantation of Hematopoietic Cells from MLL-AF9 Transgenic Mice].
Long WY; Shen X; Xing S; Xiong GL; Wang HG; Yu ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1369-1374. PubMed ID: 34627412
[TBL] [Abstract][Full Text] [Related]
18. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia.
Waclawiczek A; Hamilton A; Rouault-Pierre K; Abarrategi A; Albornoz MG; Miraki-Moud F; Bah N; Gribben J; Fitzgibbon J; Taussig D; Bonnet D
J Clin Invest; 2020 Jun; 130(6):3038-3050. PubMed ID: 32364536
[TBL] [Abstract][Full Text] [Related]
20. Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cells.
Yehudai-Resheff S; Attias-Turgeman S; Sabbah R; Gabay T; Musallam R; Fridman-Dror A; Zuckerman T
Int J Cancer; 2019 May; 144(9):2279-2289. PubMed ID: 30548585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
